Teoh, E., Bridges, E., Morotti, M., Zois, C., Lord, S., Gleeson, F., & Harris, A. (2017). Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer. Springer.
Chicago Style (17th ed.) CitationTeoh, EJ, EM Bridges, M. Morotti, CE Zois, SR Lord, FV Gleeson, and AL Harris. Fluciclovine Is a Potential Imaging Biomarker of Glutamine Utilisation in Breast Cancer. Springer, 2017.
MLA引文Teoh, EJ, et al. Fluciclovine Is a Potential Imaging Biomarker of Glutamine Utilisation in Breast Cancer. Springer, 2017.
警告:這些引文格式不一定是100%准確.